GRAIL, LLC, a subsidiary of Illumina, Inc., currently held separate from Illumina, Inc., under the terms of the Interim Measures Order of the European Commission dated 29 October 2021, Menlo Park, CA
Alvin Shi , Abdullah Ali , Gordon Cann , Rita Shaknovich , Oliver Venn , Azra Raza , Qinwen Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2017 ASCO Annual Meeting
First Author: Koichi Takahashi
2016 ASCO Annual Meeting
First Author: Maro Ohanian
2023 ASCO Annual Meeting
First Author: Maha AT Elsebaie
2022 ASCO Annual Meeting
First Author: Nai-Jung Chiang